Inhalation Drug Delivery: The Impact of Particle Size Reduction
Pharmaceutical Technology, September 2, 2019
Oops! Your browser version is not supported by our website.
Please use these following browsers to view this page:
Pharmaceutical Technology, September 2, 2019
High Performance, High-Dose Capsule DPI.
Excipient and delivery device selection play crucial roles in the formulation of inhaled drugs.
Hovione is a global expert in particle engineering, an essential technology when developing inhalation drug products.
Hovione, the specialist integrated CDMO, leader in spray drying and particle engineering, and H&T Presspart have entered in a strategic partnership to advance the development of Presspart's Sunriser© Capsule-based Dry Powder Inhaler platform.
Drug Delivery Technology, April 2007
Drug Development & Delivery, April 16, 2020